Skip to main content

bioAffinity Technologies, Inc.

BIAF
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001712762

No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $782.5K in total; no superinvestor holds it.

Other share classesBIAFW

Q2 2025 vs. Q1 2025

How the institutions holding bioAffinity Technologies, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of BIAF: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders17117+1
Shares512.3K53.7K362.3K−96.2K (−21.0%)
Value$132.3K$14.0K$104.0K−$14.3K (−12.1%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held bioAffinity Technologies, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to BIAF in Q2 2025
InstitutionSharesValue% of portfolio
Allworth Financial LP53,734$15.4K0.00%
StoneX Group Inc.15,206$4.37K0.00%
Sprott Inc.10,000$2.87K0.00%
Citigroup Inc1,478$4240.00%
Raymond James Financial Inc500$1440.00%
UBS Group AG24$70.00%

Sold out (5)

Institutions that held bioAffinity Technologies, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of BIAF in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Warberg Asset Management LLC22,500$5.87K
Van Hulzen Asset Management, LLC16,012$4.16K
HRT Financial LP18,841$4.00K
Barclays PLC3,181$827
JPMorgan Chase & Co18$5

Not filed for Q2 2025 yet (1)

Institutions that held bioAffinity Technologies, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BIAF in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Sheaff Brock Investment Advisors, LLC53,734$14.0K